Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dedan Kinoti"'
Autor:
Samuel K. Martin, J. R. Rashid, Christian T. Bautista, Jeffrey R. Ryan, Monique Wasunna, Dedan Kinoti, Charles Magiri, Shadrak O. Odera, Jane Mbui, Adeline S. T. Chan, Lisa P. Hochberg, Phillip M. Ngumbi, G. Kirigi
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 74:308-317
Visceral leishmaniasis (VL) seroprevalence in Kenya is unknown because of the lack of a practical and accurate diagnostic test or surveillance system. A novel serological assay was used to estimate the seroprevalence of Leishmania-specific antibodies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94bec9a9b94c4ab556b453918c062fd0
https://doi.org/10.4269/ajtmh.2006.74.308
https://doi.org/10.4269/ajtmh.2006.74.308
Autor:
Jeffrey R, Ryan, Jane, Mbui, Juma R, Rashid, Monique K, Wasunna, George, Kirigi, Charles, Magiri, Dedan, Kinoti, Phillip M, Ngumbi, Samuel K, Martin, Shadrak O, Odera, Lisa P, Hochberg, Christian T, Bautista, Adeline S T, Chan
Publikováno v:
The American journal of tropical medicine and hygiene. 74(2)
Visceral leishmaniasis (VL) seroprevalence in Kenya is unknown because of the lack of a practical and accurate diagnostic test or surveillance system. A novel serological assay was used to estimate the seroprevalence of Leishmania-specific antibodies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::26a0fb9096bd2b678ff254356f4c0b33
https://pubmed.ncbi.nlm.nih.gov/16474089
https://pubmed.ncbi.nlm.nih.gov/16474089
A phase II dose-increasing study of sitamaquine for the treatment of visceral leishmaniasis in Kenya
Autor:
Monique K, Wasunna, Juma R, Rashid, Jane, Mbui, George, Kirigi, Dedan, Kinoti, Hudson, Lodenyo, J Mark, Felton, Antony J, Sabin, M John, Albert, John, Horton
Publikováno v:
The American journal of tropical medicine and hygiene. 73(5)
Sitamaquine (WR6026) is an 8-aminoquinoline in development for the oral treatment of visceral leishmaniasis (VL). This was an open-label, dose-increasing study to determine the dose-response and safety profile for sitamaquine in Kenyan patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::48119b898dad4d3d284c3032390238a7
https://pubmed.ncbi.nlm.nih.gov/16282296
https://pubmed.ncbi.nlm.nih.gov/16282296
Autor:
G. Kirigi, Monique Wasunna, R. J. Rashid, G Mutuma, Dedan Kinoti, Jane Mbui, R Kipmutai, P. M. Nyakundi, H Lodenyo
Publikováno v:
East African Medical Journal; Vol 80, No 8 (2003): ; 440-442
We report a rare case of visceral leishmanisis with concomitant post kala-azar dermal leishmaniasis as the initial presentation in a female patient from Baringo district, Rift valley province, Kenya.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39087c89e20baacd1988e17e8cdc49f1
https://www.ajol.info/index.php/eamj/article/view/8738
https://www.ajol.info/index.php/eamj/article/view/8738
Publikováno v:
Transactions of the Royal Society of Tropical Medicine and Hygiene. 96(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90d773c09519481de17c01a07dac105c
https://pubmed.ncbi.nlm.nih.gov/12474482
https://pubmed.ncbi.nlm.nih.gov/12474482
Autor:
Tansy Edwards, Eltahir A G Khalil, Raymond Omollo, Abuzaid A. Abuzaid, Monique Wasunna, Sally Ellis, Thomas P. C. Dorlo, Njenga Njoroge, Dedan Kinoti, Brima M. Younis, Manica Balasegaram, Neal Alexander, G. Kirigi, Ahmed Eleojo Musa
Publikováno v:
Trials
Trials, 12(1). BioMed Central
Trials, Vol 12, Iss 1, p 166 (2011)
Trials, 12(1). BioMed Central
Trials, Vol 12, Iss 1, p 166 (2011)
Background Treatment options for Visceral Leishmaniasis (VL) in East Africa are far from satisfactory due to cost, toxicity, prolonged treatment duration or emergence of parasite resistance. Hence there is a need to explore alternative treatment prot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da2bdf2eba43d7884200b80e13cc120b
http://europepmc.org/articles/PMC3155829
http://europepmc.org/articles/PMC3155829